Sat. Feb 4th, 2023

Sabela Ojea

Levi Strauss & Co. said Wednesday that it expects revenue and earnings growth in 2023 after beating analysts expectations for the last quarter of 2022. Shares of the jeans marker gained 6.4% in after-hours trading.

Ocuphire Pharma Inc. said its APX3330 treatment for the diabetic retinopathy eye disease didn’t meet the primary endpoint…



Source link